| Medical Policy Name | Summary of Changes |
|---|---|
| Medicare Part C Medicare Coverage Policy Temporomandibular Joint Dysfunction Surgery | Annual Review. Updated language to align with Corporate Policy. Added references to include Medicare Benefit Policy and MCG guidelines. No change to policy intent |
| Medicare Part C Medicare Coverage Policy Forsee AMD Home Monitoring | Annual Review. Added references Added indication for non-coverage per external physician review No change to policy intent. |
| Medicare Part C Medicare Coverage Policy Upper Limb Prosthetics | Annual Review. This policy was updated as the codes on this policy are billed under prosthetic benefit and therefore require prior approval from the Plan. No CMS guidance to update. Myoelectric codes removed as they are now billed under DME benefit. Added references No change to policy intent. |
| Medicare Part C Medicare Coverage Policy Ambulance and Medical Transport Services | Converted to a Policy in the absence of an NCD or LCD. No CMS Guidance updates. Added additional language regarding the criteria for a fixed or rotary winged ambulance. Added references No change to policy intent. |
| Medicare Part C Medical Coverage Policy Intensive Outpatient Program (IOP) Behavioral Health | Newly created policy for MA Behavioral Health in absence of an NCD or LCD accessed on 08/18/2025 |
| Medicare Part C Medical Coverage Policy Pneumatic Compression Device for Chest, Trunk, Abdomen, Head and Neck | Newly created policy in the absence of CMS guidance on the use of a PCD for chest, trunk or abdomen as standalone treatment. |
| Medicare Part C Medical Coverage Policy Bioengineered Skin and Soft Tissue Substitute for Breast Reconstruction, Epidermolysis Bullosa Dystrophica (EBD), and Severe Burns | Newly created policy in absence of current NCD, LCD and LCA. Blue Cross and Blue Sheild NC Corporate Policy Skin and Soft Tissue Substitutes; Originated January 1994 via Skin and Soft Tissue Substitutes | Providers | Blue Cross NC accessed on 08/11/2025 Proposed LCD-Skin Substitute Grafts/Cellular and Tissue-Based Products for the Treatment of Diabetic Foot Ulcers and Venous Leg Ulcers (DL39806) accessed on 8/11/2025 Proposed Local Coverage Article (LCA) Billing and Coding: Skin Substitutes Grafts/Cellular Tissue-Based Products for the Treatment of Diabetic Foot Ulcers and Venous Leg Ulcers Draft Article - Billing and Coding: Skin Substitutes Grafts/Cellular Tissue-Based Products for the Treatment of Diabetic Foot Ulcers and Venous Leg Ulcers (DA59740) accessed on 8/11/2025 |
Blue Cross and Blue Shield of North Carolina does not discriminate on the basis of race, color, national origin, sex, age or disability in its health programs and activities. Learn more about our non-discrimination policy and no-cost services available to you.
Information in other languages: Español 中文 Tiếng Việt 한국어 Français العَرَبِيَّة Hmoob ру́сский Tagalog ગુજરાતી ភាសាខ្មែរ Deutsch हिन्दी ລາວ 日本語
© 2025 Blue Cross and Blue Shield of North Carolina. ®, SM Marks of the Blue Cross and Blue Shield Association, an association of independent Blue Cross and Blue Shield plans. All other marks and names are property of their respective owners. Blue Cross and Blue Shield of North Carolina is an independent licensee of the Blue Cross and Blue Shield Association.